Columnist Jennifer Lynne reflects on her most-read columns from last year and why those stories resonated with the hemophilia community.

Columnist Joe MacDonald's son struggled to balance school and hemophilia during his first semester of college. Now, he's better prepared.

MacDonald worries about her adult son being complacent when it comes to administering his hemophilia medication.

Columnist G Shellye Horowitz wasn't surprised to learn she had osteopenia, as her bleeding disorder increases her risk of low ...

Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended ...

Columnist Alliah Czarielle says a conversation she had with her husband about manual wheelchairs surprised her.

The U.S. FDA has approved Alhemo, given as once-daily injections, to help prevent bleeds in patients with hemophilia A or B ...